All month long Missouri Partnership is taking a look back at 31 of Missouri’s biggest stories in economic development from the past year. Today we take a look back at Pfizer’s expansion and what it means for the Show-Me-State.
On November 22, Pfizer Inc., a global biopharmaceutical company, announced plans to expand their new Chesterfield, Missouri, campus with a $200 million state-of-the-art R&D facility. More than 80 new jobs are expected to be created by the expansion, which will begin construction next year.
“Missouri is an important part of Pfizer’s R&D network, and we’re proud of the world-class employee base we’ve built here,” said John Ludwig, Senior Vice President of BioTherapeutics Research for Pfizer. “Thanks to the support we’ve received from the state of Missouri, St. Louis County and Chesterfield, our new St. Louis laboratory facility will provide the right location and space as we continue to evolve our business over the coming years.”
Pfizer’s continued success in Missouri is a testament to the state’s role as the global leader in agtech. In addition to Pfizer, Missouri is also home to agtech giants such as Monsanto, Cargill, BASF and Bayer as well as world-class research institutions such as the Danforth Plant Science Center and AgriLabs.